- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 471/08 - Bridged systems
Patent holdings for IPC class C07D 471/08
Total number of patents in this class: 1965
10-year publication summary
|
134
|
124
|
147
|
152
|
164
|
152
|
167
|
172
|
137
|
88
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4898 |
66 |
| Merck Sharp & Dohme LLC | 3748 |
57 |
| Wockhardt Limited | 225 |
49 |
| Boehringer Ingelheim International GmbH | 4650 |
40 |
| Purdue Pharma L.P. | 499 |
39 |
| Neurosearch A/S | 185 |
36 |
| Meiji Seika Pharma Co., Ltd. | 248 |
34 |
| Novartis AG | 10849 |
31 |
| Gilead Sciences, Inc. | 2036 |
29 |
| Skyhawk Therapeutics, Inc. | 110 |
26 |
| Nippon Chemiphar Co., Ltd. | 229 |
24 |
| Achillion Pharmaceuticals, Inc. | 164 |
22 |
| Janssen Pharmaceutica N.V. | 3392 |
21 |
| Vertex Pharmaceuticals Incorporated | 1597 |
21 |
| Hoffmann-La Roche Inc. | 3418 |
18 |
| Pfizer Inc. | 3387 |
18 |
| Centre National de La Recherche Scientifique | 10418 |
18 |
| Takeda Pharmaceutical Company Limited | 2713 |
18 |
| Merck Patent GmbH | 5831 |
17 |
| Amgen Inc. | 4074 |
17 |
| Other owners | 1364 |